Adjuvant therapy in resectable gastric cancer
نویسندگان
چکیده
منابع مشابه
Neoadjuvant or adjuvant therapy for resectable gastric cancer? A practice guideline.
OBJECTIVE To make recommendations on the use of neoadjuvant or adjuvant therapy in addition to surgery in patients with resectable gastric cancer (T1-4, N1-2, M0). OPTIONS Neoadjuvant or adjuvant treatments compared with "curative" surgery alone. OUTCOMES Overall survival, disease-free survival, and adverse effects. EVIDENCE The MEDLINE, CANCERLIT and Cochrane Library databases and releva...
متن کاملAdjuvant Therapy for Resectable Colorectal Cancer Liver Metastases
The most effective treatment for liver metastases from colorectal cancer is surgical resection. When curative resection is possible, a 5-year survival rate of 25% to 58% can be expected; the mortality rate associated with surgery is as low as 1% to 5% (Adson et al., 1984; Huges et al., 1986; Scheele et al., 1995; Nordlinger et al., 1996; Jamison et al., 1997; Iwatsuki et al., 1999; Fong et al.,...
متن کاملOutcomes of radiation therapy for resectable M0 gastric cancer
Background The role of radiaotion therapy in resectable gastric cancer patients without distant metastases remains controversial. This retrospective analysis was performed to identify whether resectable gastric cancer patients without distant metastases might benefit from radiation. Results The results of the Kaplan-Meier analysis and log-rank test showed that a total of 3309 patients had a M...
متن کاملPerioperative or postoperative therapy for resectable gastric cancer?
The long-term survival of gastric cancer patients is determined by the stage of the disease and therefore, by the tumor extension beyond the gastric wall and by the nodal involvement. Tumor confined to the mucosa and submucosa (T1–T2 N0 M0) has a 5-year survival of at least 70%, while invasion into the serosa increases the risk of lymph node metastases with a proportionate reduction of the 5-ye...
متن کاملAdjuvant Drug Treatment for Resectable Breast Cancer.
Breast cancer is the most common life-threatening malignancy in Western women and the second most common cause of cancer-related death. A paradox in the care of patients with breast cancer is the observation that the majority appear to be curable at the time of initial surgery, yet a large number later experience relapse followed by death from disease. To combat this problem, systemic drug ther...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Cancer
سال: 1992
ISSN: 0007-0920,1532-1827
DOI: 10.1038/bjc.1992.399